Final trade time! Let's go around the horn...

$MO $MLPX $KRE $CDE

$INSM more than doubling today on positive phase three lung drug trial results

CEO Will Lewis breaks down the key findings from this study, and how soon this drug could help patients:

Elon Musk's xAI just secured $6B of funding at a $24B valuation, so what does that mean for $NVDA and the rest of the chip space as money floods AI?

Guy Adami, @TimSeymour, Dan Nathan, and Courtney (Dominguez) Garcia, CFP®️ break down whether this wild ride is close to ending:

$CAVA slipping despite an earnings beat.

With the stock near records, Guy Adami says it's too expensive and @TimSeymour says it's 'lunacy'

What's keeping inflation higher than the Fed wants?

@EconGuyRosie shares his views on where particularly sticky elements are coming from, and whether the Fed is chasing the wrong indicators:

'Extend and pretend'

Ominous signs in the corporate real estate market could point to the next shoe to drop in this market as high interest rates batter the space

Guy Adami, @TimSeymour, Dan Nathan, and Courtney (Dominguez) Garcia, CFP®️ share their thoughts

This new weight loss drug ETF bets big on two of the industry's leading players cnb.cx/3yBSlSA (via CNBC's ETF Edge and Anna Gleason)

Final trades!

Here's what @michael_khouw @riskreversal @carterbworth and Steve Grasso are trading

$UAL $NKE $SLV $CRSP

A chart of the week bonanza!

@michael_khouw @riskreversal @carterbworth and Steve Grasso share their top charts.

$EADSY $ML $IP $FSLR

$DELL earnings on deck!

The OG options action crew reuniting for $DELL options.

We run through implied moves, technical levels to watch and the trade.

Inflation is pushing the restaurant industry to the brink, warns long-time Applebee’s franchisee Zane Tankel

He also runs through other issues weighing on the industry:

Keying in on the financials!

@carterbworth lays out the key levels to watch for $GS and $AXP and how he'd set up the trade for both.

Rally on?

Markets trading at record-highs, but is there a correction coming?

@riskreversal Steve Grasso @carterbworth and @michael_khouw debate where the strength in the market lies.

Final Trades! KayneAndersonRudnick's Julie Biel, Tim Seymour, Karen Finerman and Steve Grasso go around the horn. $HQI $IP $ULTA $WRK

'The point is, there's still a ton of demand for these planes long-term.'

Morningstar Equity Analyst Nicolas Owens doubles down on his Overweight rating on Boeing, even as the CFO warns the company could be cash flow negative this year. $BA

Breaking: The SEC approves exchange applications to list spot Ether ETFs. Contessa Brewer reports and $ETHE holder Steve Grasso weighs in.

Which companies are set to feel the $NVDA halo effect the most?

Gene Munster lays out his picks and the timeline for AI adoption. $TSM $ASML $GOOGL $META

Missed the move in $NVDA after earnings? Don't fret, because Michael C. Khouw has a way to play the bounce with options.

.LPL Financial's Adam Turnquist, CMT says $NVDA's technicals suggest the stock can keep churning higher! Why he thinks shares could surge to $1,350:

Major averages all closing lower, with the Dow notching its worst day in more than a year. The move coming on the heels of $NVDA's post-earnings surge and an upbeat PMI read.

Tim Seymour, Karen Finerman, Steve Grasso and KayneAndersonRudnick's Julie Biel debate what's driving the action.